Extended spectrum beta-lactamases in Eschericia coli isolated from community-acquired urinary tract infection in the Gazi Strip, Palestine

Annals of Saudi Medicine

Volumn 24, Issue 1, 2004, Pages 55-57

  Astal, Z ^a   Sharif, F A ^a   Abdallah, Soad A ^b   Fahd, Mona I ^b  

^a ISLAMIC UNIVERSITY OF GAZA   (Palestine)

^b AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BETA LACTAMASE; CEFALEXIN; CEFOTAXIME; CEFPODOXIME; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; NALIDIXIC ACID; NITROFURANTOIN; TETRACYCLINE;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; COLONY FORMING UNIT; CONTROLLED STUDY; ENTEROBACTER INFECTION; ESCHERICHIA COLI; FEMALE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OUTPATIENT CARE; PALESTINE; PRIORITY JOURNAL; SCREENING TEST; URINARY TRACT INFECTION; URINE CULTURE;

EID: 1042292580     PISSN: 02564947     EISSN: None     Source Type: Journal    
DOI: 10.5144/0256-4947.2004.55     Document Type: Article

References (17)

1. Yates RR. New Intervention strategies for reducing antibiotic resistance. Chest. 1999;115:24-27.
2. Luzzaro F, Perilli M, Amicosante G, Lombardi G, Belloni R, Zollo A, bianchi C, Toniolo A. Properties of multi-drug resistant ESBL-producing Proteus mirabilis isolates and possible role of beta-lactam/beta-lactamase inhibitor combinations. Int J Antimicrobial Agents. 2001;17(2): 131-135.
3. Kaye KS, Fraimow HS, Abrutyn E. Pathogens resistant to antimicrobial agents. Epidemiology, molecular mechanisms and clinical management. Infect Dis Clin North Am. 2000,12(2)293-319.
4. Hobson RP, MacKenzie FM, Gould IM. An outbreak of multiply-resistant Klebsiella pneumoniae in the Grampion region of Scotland. J Hosp Infect, 1996;33: 249-62.
5. Cormican M, Morris D, Corbett-Feeney G, Flynn J. Extended spectrum beta-lactamase production and fluorquinolone resistance in pathogens associated with community acquired urinary tract infection. Diag Microbiol Infect Dis.1998;32:317-319.
6. Goossens H, Sprenger MJW. Community-acquired infections and bacterial resistance. Brit Med J. 1998;317:654-657.
7. Baron EJ, Peterson LR, Finegold SM. Diagnostic microbiology. 9th ed. Mosby Year Book. USA 168-186, 250-55 (1994).
8. Burnett RW, Haber MH, Hackel E, Hanson CA, Keren DF, Lee-Lewandrowski E. Clinical laboratory medicine. Williams &Wilkins. Philadelphia USA. 1113-20.(1994)
9. Vendepitte J, EL-Nageh MM, Tikhomirov E, Stelling JM, Estrela A. Guideline for antimicrobial resistance surveillance. WHO Regional Publications. Eastern Mediterranean Series 15. Alexandria. 13-22 (1996).
10. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Eleventh Informational Supplement. Document M100-S11. Vol. 21. No. 1. NCCLS, Wayne PA (2001).
11. Stobberingh EE, Arends J, Hoogkamp-Korstanje JA, Goessens WH, Visser MR, Buiting AG, Debets-Ossenkopp YJ, van Ketel, RJ, van Ogtrop ML, Sabbe LJ, Voorn GP, Winter HL, van Zeijl JH. Occurrence of extended-spectrum beta-lactamases in Dutch hospitals. Infection. 27(6): 348-54 (1999).
12. De Champs C, Sirot D, Chanal C, Bonnet R, Sirot J. A 1998 survey of extended-spectrum beta-lactamases in enterobacteriaceae in France. Antimicrobial Agents and Chemotherapy. 2000,44(11):3177-3179.
13. Vatopoulos AC, Philippon A, Tzouvelekis LS, Komninou Z, Legakis NJ. Prevalence of transferable SHV-5 type betalactamase in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Greece. J Antimicrob Chemother. 1990;26(5):635-48.
14. Pai,H, Lyu S, Lee JH, Kim J, Kwon Y, Choe KW. Survey of extended-spectrum beta-lactamases in clinical isolates of Escherichia coli and Klebsiella pneumoniae: prevalence of TEM-52 in Korea. J Clin Microbiol. 1999;37(6):1758-63.
15. Saurina G, Quale JM, Manikal VM, Oydna, E. Landman D. Antimicrobial resistance in enterobacteriaceae in Brooklyn, NY: epidemiology and relation to antibiotic usage patterns. Antimicrobial Agents and Chemotherapy. 2000;45:895-8.
16. Jett BD, Ritchie DJ, Reichley R, Bailey TC, Sahm DF. In vitro activities of various beta-lactam antiomicrobial agents against clinical isolates of Eschericia coli and Klebsiella species resistant to oxyimino cephalosporins. Antimicrobial Agents and Chemotherapy. 1995;39(5): 1187-1190.
17. Livermore DM, Yuan M. antibiotic resistance and production of extended-spectrum beta-lactamases amongst Klebsiella spp from intensive care units in Europe. J Antimicrob Chemother. 1996;38:409-24.